SOLENO THERAPEUTICS INC Balance Sheet
SLNO / Health Care|13 years of annual SEC 10-K data (FY2013-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 13 fiscal years. All figures from audited SEC 10-K filings.
SOLENO THERAPEUTICS INC had $564M in total assets and $450M in shareholders' equity as of FY2025. Total debt was $50M against $70M in cash, resulting in a $20M net cash position.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $70.1M | $87.9M | $169.7M | $14.6M | $21.3M | $49.2M | $20.7M | $23.1M | $17.1M | $2.7M | $5.5M | $8.0M | $1.3M |
| Accounts Receivable | $28.2M | - | - | - | - | - | - | $0 | - | $133.3K | $156.1K | $0 | $149.6K |
| Inventory | $15.0M | - | - | - | - | - | - | $0 | - | $660.4K | $551.0K | $109.3K | - |
| Current Assets | $355.8M | $293.9M | $171.4M | $15.6M | $22.4M | $50.2M | $21.1M | $24.7M | $18.0M | $3.8M | $6.4M | $8.3M | $1.5M |
| PP&E (Net) | $185.0K | $186.0K | $12.0K | $26.0K | $33.0K | $19.0K | $22.0K | $12.0K | $23.0K | $42.0K | $85.7K | $57.6K | $63.2K |
| Goodwill | - | - | - | - | - | - | - | - | - | $817.5K | $916.8K | $0 | - |
| Total Assets | $563.8M | $331.0M | $180.7M | $26.5M | $35.6M | $65.0M | $38.2M | $43.2M | $39.0M | $5.6M | $8.2M | $8.4M | $1.6M |
| Current Liabilities | $61.4M | $18.7M | $11.5M | $7.3M | $8.0M | $8.6M | $5.0M | $1.9M | $1.7M | $1.7M | $3.2M | $1.3M | $14.2M |
| Total Debt | $49.9M | $49.8M | - | - | - | - | - | - | - | - | - | - | - |
| Shareholders' Equity | $450.1M | $245.1M | $157.5M | $10.3M | $17.8M | $45.5M | $14.9M | $30.4M | $26.8M | $3.4M | $3.2M | -$11.2M | -$34.2M |